5
Funding Rounds
$5.1m
Money raised
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
2
Funding Rounds
$158.0m
Money raised
Senti Biosciences is a synthetic biology company.
Industries:
Key people:
- Timothy Lu ***.**@sentibio.com
- Philip Lee ******.***@sentibio.com
- Wilson Wong
2
Funding Rounds
$13.8m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
Industries:
Location:
Key people:
2
Funding Rounds
$164.5m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
Industries:
Location:
Key people:
- Steve Shamah *******@obsidiantx.com
- Tariq Kassum *****@curie.bio
- Michael Gilman linkedin
2
Funding Rounds
$67.5m
Money raised
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
Industries:
Location:
Key people:
2
Funding Rounds
$18.1m
Money raised
A biotechnology company that develops treatments for cancer and hematologic conditions
Industries:
Location:
Key people:
4
Funding Rounds
$743.2m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
Industries:
Key people:
- Daphne Koller ******@insitro.com
2
Funding Rounds
$386.0m
Money raised
Focused on transforming lives of patients with immune dysfunctions and cancer
5
Funding Rounds
$26.0m
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
Industries:
Location:
Key people:
1
Funding Rounds
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
2
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
Industries:
Location:
1
Funding Rounds
$7.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
Industries:
Key people:
1
Funding Rounds
$42.2m
Money raised
Soteria Biotherapeutics is a biotechnology company developing cancer immunotherapies.
Industries:
Location:
Key people:
- Alexander Martinko linkedin
- James Wells
- Zachary Hill *****@montaratx.com
2
Funding Rounds
$33.8m
Money raised
A company developing immune therapies for cancer and related diseases
Industries:
Location:
Key people:
2
Funding Rounds
$173.0k
Money raised
XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.
Industries:
Key people:
1
Funding Rounds
$71.5m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
1
Funding Rounds
$35.0m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$2.5m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.
2
Funding Rounds
$10.0m
Money raised
Macomics is an Edinburgh-based immuno-oncology company.
Industries:
Location:
Key people:
- Prof. Jeffrey W. Pollard *******@macomics.com
- Dr. Luca Cassetta ********@macomics.com
- Dr. Robert Haigh *****@macomics.com
1
Funding Rounds
$40.0m
Money raised
Taiga Biotechnologies is a biotechnology company developing blood stem cell therapies for treating infectious diseases and cancer.
Industries:
Location:
4
Funding Rounds
$37.4m
Money raised
NewLink Genetics is a biopharmaceutical company focused on the discovery and development of immuno-oncology products.
Industries:
Location:
2
Funding Rounds
$163.0m
Money raised
A biotechnology company offering precision immunotherapy cancer treatments.
Industries:
Key people:
- Andy Yeung ****@asherbio.com
- Ivana Djuretic *****@asherbio.com
1
Funding Rounds
$104.4m
Money raised
Unum Therapeutics is a biotechnology company developing cell therapy products for cancer immunotherapy applications.
3
Funding Rounds
$171.2m
Money raised
Triumvira Immunologics is an adoptive Immunotherapy founded by Jonathan Bramson.
Industries:
Location:
Key people:
1
Funding Rounds
$5.0m
Money raised
WindMIL Therapeutics is a biotechnology company developing cell therapy products for treating cancer.
Industries:
Location:
2
Funding Rounds
$26.0m
Money raised
Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.
Industries:
Location:
1
Funding Rounds
SpecificiT Pharma is a biotechnology company developing cancer immunotherapies using stem cells.
Industries:
2
Funding Rounds
$20.5m
Money raised
ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.
Industries:
Location:
Key people:
4
Funding Rounds
$166.8m
Money raised
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.
Industries:
Location:
2
Funding Rounds
$160.0m
Money raised
CatalYm is an innovative immunotherapies developer for cancer patients founded in 2016.
Industries:
Location:
2
Funding Rounds
$2.7m
Money raised
OncoImmunity is a personalized cancer immunotherapy using machine learning company founded in 2014 by Trevor Clancy, Richard Stratford and Trevor Clancy.
Industries:
Key people:
3
Funding Rounds
$260.0m
Money raised
Antibody Therapies
Location:
2
Funding Rounds
$121.4m
Money raised
Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.
Industries:
Key people:
4
Funding Rounds
$129.5m
Money raised
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
Industries:
Location:
3
Funding Rounds
$29.5m
Money raised
Aivita Biomedical is a stem Cell Therapy founded in 2016.
Location:
Key people:
1
Funding Rounds
$22.0m
Money raised
Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next-generation immunotherapeutics.
Location:
Key people:
- David Burkhart *****.*.********@inimmune.com
1
Funding Rounds
$10.0m
Money raised
F1 Oncology is a biotechnology company developing CAR-T therapies for the treatment of cancer.
Industries:
Location:
1
Funding Rounds
$42.0m
Money raised
Catamaran uses NK cells, synthetic biology, and non-viral cell engineering to create novel CAR-NK cell therapies.
1
Funding Rounds
$166.0m
Money raised
Rakuten Medical is an antibody conjugates for cancer founded by Hiroshi Mikitani.
2
Funding Rounds
$75.0m
Money raised
Oncolytic Immunotherapy
Location:
1
Funding Rounds
$7.0m
Money raised
Leman Biotech is an AI-enabled metabolic cancer immunotherapy founded in 2021.
Industries:
Location:
1
Funding Rounds
$175.0m
Money raised
Affini-T Therapeutics, Inc is a TCR Cell Therapy.
Industries:
Location:
1
Funding Rounds
$20.0m
Money raised
Novasenta Inc. is a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies.
Industries:
Location:
1
Funding Rounds
$80.0m
Money raised
Monoclonal Antibodies
Industries:
Location:
1
Funding Rounds
$8.0m
Money raised
Vaximm is developing oral T-cell immunotherapies to treat cancer patients.